Status:
UNKNOWN
Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia
Lead Sponsor:
An-Najah National University
Conditions:
Anesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The research will be conducted between March 2021 and June 2023. All patients scheduled electively for one of four surgeries (Laparoscopic Cholecystectomy, Submucosal resection, Breast lumpectomy, and...
Detailed Description
* After signing the informed consent, each participant will undergo standard care for any surgical patient (general examination, vital signs recording, history taking, and cannula insertion). Then, a ...
Eligibility Criteria
Inclusion
- Age \> 18-year-old.
- Patients undergoing elective surgeries under general anesthesia.
- American Society of Anesthesiology grade 1 or 2.
- BMI 18-35 Kg/m2
- Reliable participant (he/she can give history by him/herself)
Exclusion
- Current Pregnancy or breastfeeding.
- Chronic use of analgesia (use of any analgesic drug for most days in the last three months).
- Current use of analgesia (within last 24 hours).
- Allergy to any medication used in the study.
- Smoking or Nargila use within last 24 hour before surgery and until discharge.
- History of psychiatric medication or disease.
- Discharge from hospital within 6 hours after surgery.
- Participants transferred from the ward to ICU or other wards.
- Known case of liver or kidney impairment.
- History of alcohol use or illicit drug.
- Any complication during surgery leads to changes in protocol of the study.
Key Trial Info
Start Date :
August 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05389813
Start Date
August 15 2021
End Date
May 1 2024
Last Update
July 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
An-Najah National University Hospital
Nablus, Wes-Bank, Palestinian Territories, 7704